阿哌沙班急性过量后无出血:首例多时间点血药浓度病例报告
本文报告一例62岁女性在吞服其配偶的阿哌沙班60片(每片5mg,合计5mg/kg)2小时后到急诊就诊,否认同时摄入其他药物,当天未服用自己的处方药。生命体征正常、无症状,生化与血液学检查无异常。血浆阿哌沙班浓度在摄入后14小时为2765.6 ng/ml,半衰期呈非线性。全程未使用血制品或凝血因子替代,从未出血,血红蛋白未下降。作者认为该病例表明单次阿哌沙班过量可无任何并发症发生。
要点
- 62岁女性单次吞服阿哌沙班5mg/kg(60片×5mg),2小时后到急诊,生命体征正常且无症状。
- 摄入后14小时血浆阿哌沙班浓度为2765.6 ng/ml,半衰期呈非线性。
- 全程未使用血制品或凝血因子替代,从未出血,血红蛋白未下降。
- 该病例是首例伴多个血清药物浓度、有助于判断过量动力学的阿哌沙班过量病例报告。
适用人群与场景
- 单次急性阿哌沙班过量、无同时摄入其他药物、到急诊时无症状且生命体征正常的成人患者(本例为62岁女性,吞服配偶的阿哌沙班5mg/kg)。
研究设计与关键结果
- 病例报告:62岁女性吞服阿哌沙班60片(每片5mg,合计5mg/kg)后2小时到急诊,否认同时摄入其他药物,当天未服用自己的处方药。
- 生命体征正常、无症状,生化与血液学检查无异常;摄入后14小时血浆阿哌沙班浓度为2765.6 ng/ml,半衰期呈非线性。
- 未使用血制品或凝血因子替代,从未出血,血红蛋白未下降。
证据类型、等级与局限
- 证据类型:病例报告;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该病例表明单次阿哌沙班过量可无任何并发症发生。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
We present an acute apixaban overdose without reported coingestants; it is the first such case report associated with multiple serum drug levels to assist in determining overdose kinetics. A 62 year old female presented to an emergency department (ED) 2 hours after ingesting sixty 5 mg tablets (5mg/kg) of her spouse's apixaban medication. She denied coingestants, and did not take her prescribed medications that day. Her vital signs were normal and she denied symptoms. Chemistry and hematology labs were unremarkable. Plasma apixaban concentrations were 2765.6 ng/ml at 14 hours post ingestion with a non-linear half life. There was no utilization of blood products or factor replacement. There was never any bleeding, and her hemoglobin did not decrease. This case demonstrates that a single ingestion of apixaban can occur without any complications occurring.
参考来源
- Leikin SM, Patel H, Welker KL, et al. The X factor: Lack of bleeding after an acute apixaban overdose. Am J Emerg Med. 2016. PMID: 27884586. doi:10.1016/j.ajem.2016.11.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。